These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11983513)

  • 21. [Enzymatic resolution of racemic naproxen in a low aqueous-organic biphase system].
    Xin JY; Li SB; Xu Y; Wang LL; Shen RN
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):55-9. PubMed ID: 10883277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism-based catalytic antibody inactivation.
    Angeles TS; Martin MT
    Biochem Biophys Res Commun; 1993 Dec; 197(2):696-701. PubMed ID: 8267606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced catalysis and enantioselective resolution of racemic naproxen methyl ester by lipase encapsulated within iron oxide nanoparticles coated with calix[8]arene valeric acid complexes.
    Sayin S; Akoz E; Yilmaz M
    Org Biomol Chem; 2014 Sep; 12(34):6634-42. PubMed ID: 25012138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-catalyzed degradation of cocaine.
    Landry DW; Zhao K; Yang GX; Glickman M; Georgiadis TM
    Science; 1993 Mar; 259(5103):1899-901. PubMed ID: 8456315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspects of antibody-catalyzed primary amide hydrolysis.
    Titmas RC; Angeles TS; Sugasawara R; Aman N; Darsley MJ; Blackburn G; Martin MT
    Appl Biochem Biotechnol; 1994; 47(2-3):277-90; discussion 291-2. PubMed ID: 7944343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of three selenium-containing catalytic antibodies with high catalytic efficiency using a novel hapten design method.
    Su D; Ren X; You D; Li D; Mu Y; Yan G; Zhang Y; Luo Y; Xue Y; Shen J; Liu Z; Luo G
    Arch Biochem Biophys; 2001 Nov; 395(2):177-84. PubMed ID: 11697854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cocaine catalytic antibodies: the primary importance of linker effects.
    Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enantioselective enzymatic hydrolysis of racemic drugs by encapsulation in sol-gel magnetic sporopollenin.
    Yilmaz E
    Bioprocess Biosyst Eng; 2012 May; 35(4):493-502. PubMed ID: 21932062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An active immunization approach to generate protective catalytic antibodies.
    Wang J; Han Y; Wilkinson MF
    Biochem J; 2001 Nov; 360(Pt 1):151-7. PubMed ID: 11696002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A catalytic antibody programmed for torsional activation of amide bond hydrolysis.
    Aggarwal R; Benedetti F; Berti F; Buchini S; Colombatti A; Dinon F; Galasso V; Norbedo S
    Chemistry; 2003 Jul; 9(13):3132-42. PubMed ID: 12833295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-catalyzed cleavage of the D-Ala-D-Lac depsipeptide: an immunological approach to the problem of vancomycin resistance.
    Isomura S; Ashley JA; Wirsching P; Janda KD
    Bioorg Med Chem Lett; 2002 Mar; 12(6):861-4. PubMed ID: 11958980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enantioselective synthesis of (S)-naproxen using immobilized lipase on chitosan beads.
    Gilani SL; Najafpour GD; Heydarzadeh HD; Moghadamnia A
    Chirality; 2017 Jun; 29(6):304-314. PubMed ID: 28422452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of chiral and racemic phosphonate-based haptens for the induction of aldolase catalytic antibodies.
    Mu YQ; Gibbs RA
    Bioorg Med Chem; 1997 Jul; 5(7):1327-37. PubMed ID: 9377093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial production of optically active beta-phenylalanine ethyl ester through stereoselective hydrolysis of racemic beta-phenylalanine ethyl ester.
    Ogawa J; Mano J; Shimizu S
    Appl Microbiol Biotechnol; 2006 May; 70(6):663-9. PubMed ID: 16170530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel biosynthesis of (R)-ethyl-3-hydroxyglutarate with (R)-enantioselective hydrolysis of racemic ethyl 4-cyano-3-hydroxybutyate by Rhodococcus erythropolis.
    Dong HP; Liu ZQ; Zheng YG; Shen YC
    Appl Microbiol Biotechnol; 2010 Jul; 87(4):1335-45. PubMed ID: 20393698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?
    Tawfik DS; Chap R; Green BS; Sela M; Eshhar Z
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2145-9. PubMed ID: 7892238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic antibodies hydrolysing organophosphorus esters.
    Brimfield AA; Lenz DE; Maxwell DM; Broomfield CA
    Chem Biol Interact; 1993 Jun; 87(1-3):95-102. PubMed ID: 8344006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):213-33. PubMed ID: 12379363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen.
    el Mouelhi M; Ruelius HW; Fenselau C; Dulik DM
    Drug Metab Dispos; 1987; 15(6):767-72. PubMed ID: 2893700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.